Michele Vendruscolo

Michele Vendruscolo

Company: University of Cambridge & Wren Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: How to Know When a CDx & a Predictive Biomarker is Needed for a Drug 4:00 pm

Discussing criteria determining which drugs to progress for CDx selection to inform clinical strategy and investment plan Changing requirements to implement a diagnostic in the early phase clinical trial Vs what’s needed for later approval Engaging different arms of the business, to build trust for CDx development Pre-empting bottlenecks in Dx development to de-risk investmentRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.